Renhe Pharmacy Stock Hits Day Low of CNY 5.31 Amid Price Pressure

Renhe Pharmacy Co., Ltd. experienced a significant decline today, with the stock dropping by 5.65% on March 23, 2026. The stock reached an intraday low of CNY 5.31, reflecting ongoing challenges in its performance metrics. Over the past week, Renhe Pharmacy has seen a decrease of 9.95%, while its one-month performance shows a decline of 8.56%. In comparison to the broader market, represented by the China Shanghai Composite, which fell by 3.63% today, Renhe's performance has notably lagged. Year-to-date, the stock is down 5.49%, and over the past three years, it has decreased by 15.91%. Financially, the company has reported negative results for the last three consecutive quarters, with net sales for the first nine months declining by 9.98%. Despite a relatively attractive valuation indicated by a Price to Book ratio of 1.36 and a dividend yield of 2.57%, the company's long-term growth prospects appear limited, as evidenced by a five-year annual decline in net sales and operating profit. Renhe Pharmacy remains a mid-cap player in the Pharmaceuticals & Biotechnology sector, with a market capitalization of CNY 7,230 million.